MTD · Mettler-Toledo International Inc.
$1259.942026-05-17Sector: Healthcare; Industry: Medical - Diagnostics & Research; Sub-Industry: Life Sciences Tools & Services
Intrinsic Value Range Comparison · Mulya.ai
Base · active
$601
-52.3% vs market
Mulya.ai vs Analyst IV Comparison?
Mulya.ai IV range ($565 · $780) Analysts Range ($1400 · $1600) Fundamentals · historical + forward · baseitalics = DCF projection
| Period | Revenue | Rev Gr ? | Ops M% ? | Tax Rate ? | NOPAT ? | Reinvest ? | FCFF ? | WACC% ? | PV FCFF ? | ROIC ? | Inv. Cap ? | EPS ? | P/E |
|---|
| 2021.Q4 | $3.7B | — | 26.8% | 19.0% | $806MM | −$216MM | $590MM | 10.0% | — | 45.1% | $1.8B | $37.73 | — |
| 2022.Q4 | $3.9B | 5.4% | 28.7% | 18.5% | $918MM | −$219MM | $699MM | 10.4% | — | 48.8% | $2.0B | $42.81 | — |
| 2023.Q4 | $3.8B | -3.4% | 28.5% | 19.0% | $875MM | $62MM | $937MM | 10.0% | — | 45.3% | $1.9B | $38.70 | — |
| 2024.Q4 | $3.9B | 2.2% | 29.1% | 16.8% | $938MM | $8MM | $946MM | 10.6% | — | 50.1% | $1.9B | $42.35 | — |
| 2025.Q4 | $4.0B | 4.0% | 27.8% | 17.1% | $927MM | −$174MM | $753MM | 10.7% | — | 46.0% | $2.2B | $42.65 | 23.0 |
| italics below = DCF projection · 10yr Rev CAGR: 4.8% |
| 2026.Q4 | $4.2B | +5.0% | 28.0% | 17.4% | $977MM | −$111MM | $865MM | 10.3% | $784MM | 43.8% | $2.3B | $47.92 | 26.3 |
| 2027.Q4 | $4.4B | +4.9% | 28.0% | 17.7% | $1.0B | −$115MM | $906MM | 10.2% | $746MM | 43.6% | $2.4B | $50.10 | 25.1 |
| 2028.Q4 | $4.7B | +5.5% | 28.0% | 18.0% | $1.1B | −$137MM | $936MM | 10.0% | $701MM | 43.5% | $2.5B | $52.68 | 23.9 |
| 2029.Q4 | $4.9B | +5.2% | 28.0% | 18.3% | $1.1B | −$136MM | $989MM | 9.8% | $674MM | 43.2% | $2.7B | $55.20 | 22.8 |
| 2030.Q4 | $5.2B | +5.0% | 28.0% | 18.6% | $1.2B | −$140MM | $1.0B | 9.6% | $644MM | 42.9% | $2.8B | $57.75 | 21.8 |
|
| Term. Yr+ | $6.7B | 4.1% | 21.4% | 20.0% | $1.1B | −$199MM | $945MM | 8.6% | $8.4B | 23.6% | — | — | — |
Active scenario IV: $601 (-52.3% vs market)